A RARE CASE OF DUODENAL ECTROPIC CANCER
Main Article Content
Abstract
Duodenal adenocarcinoma is a rare malignancy of the gastrointestinal tract, often diagnosed at a late stage due to nonspecific symptoms. While complete surgical resection offers the best long-term survival rate, recurrence rates remain significant, with the majority of recurrences occurring within the first two years. However, specific guidelines for optimal management of recurrence after surgery for duodenal adenocarcinoma are still lacking. Treatment guidelines are based on a small number of cases or on colorectal cancer treatment protocols, posing a significant challenge for clinicians in improving patient outcomes.
This case report highlights a rare case of duodenal adenocarcinoma that underwent pancreaticoduodenectomy, lymph node dissection, and abdominal lymph node recurrence, aiming to describe a treatment strategy and contribute to the limited body of evidence for this rare and challenging condition.
Article Details
Keywords
Adenocarcinoma, duodenal cancer, small intestine cancer
References
[2] Jang B.S, Park H.J et al. Role of adjuvant chemoradiotherapy for duodenal cancer: an updated analysis of long-term follow-up from single institution. World J Surg, 2018, 42 (10): 3294-3301.
[3] Hatzaras I, Palesty J.A et al. Small-bowel tumors: epidemiologic and clinical characteristics of 1260 cases from the Connecticut tumor registry. Arch Surg, 2007, 142 (3): 229-235. doi: 10.1001/archsurg.142.3.229.
[4] Ho Xuan Tuan, Dau Quang Lieu và cộng sự. A rare case of duodenal adenocarcinoma. Radiol Case Rep, 2023, 18 (12): 4400-4403.
[5] Sun H, Liu Y et al. Prognostic factors and clinical characteristics of duodenal adenocarcinoma with survival: a retrospective study. Front Oncol, 2021, 11: 795891. doi: 10.3389/fonc.2021.795891.
[6] Kalogerinis P.T, Poulos J.E et al. Duodenal carcinoma at the ligament of Treitz: a molecular and clinical perspective. BMC Gastroenterol, 2010, 10: 109. doi: 10.1186/1471-230X-10-109.
[7] Kim M.J et al. Clinicopathological characteristics and survival of duodenal adenocarcinoma. J Korean Surg Soc, 2013, 84 (2): 83-89.
[8] Czaykowski P, Hui D. Chemotherapy in small bowel adenocarcinoma: 10-year experience of the British Columbia Cancer Agency. Clin Oncol (R Coll Radiol), 2007, 19 (2): 143-9.
[9] Han S.L, Cheng J et al. Surgically treated primary malignant tumor of small bowel: a clinical analysis. World J Gastroenterol, 2010, 16 (12): 1527-1532.